FDA Inspection
Novartis Pharma AGFDA Inspection 1180833 - Novartis Pharma AG - August 30, 2022
Record Details
This FDA Inspection record concerns Novartis Pharma AG, with an inspection on August 30, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · 32e4f411-c7ba-4f89-859a-7bb61553cc6d